| Literature DB >> 25252618 |
Ariane Leites Larentis1, Júlia Fabiana Monteiro Quintal Nicolau, Gabriela dos Santos Esteves, Daniel Tait Vareschini, Fernanda Vicente Ribeiro de Almeida, Mitermayer Galvão dos Reis, Ricardo Galler, Marco Alberto Medeiros.
Abstract
BACKGROUND: Leptospirosis is a zoonose that is increasingly endemic in built-up areas, especially where there are communities living in precarious housing with poor or non-existent sanitation infrastructure. Leptospirosis can kill, for its symptoms are easily confused with those of other diseases. As such, a rapid diagnosis is required so it can be treated effectively. A test for leptospirosis diagnosis using Leptospira Immunoglobulin-like (Lig) proteins is currently at final validation at Fiocruz.Entities:
Mesh:
Substances:
Year: 2014 PMID: 25252618 PMCID: PMC4190419 DOI: 10.1186/1756-0500-7-671
Source DB: PubMed Journal: BMC Res Notes ISSN: 1756-0500
Figure 1Scheme of LigA and LigB proteins from serovar Copenhageni adapted from Silva et al. [17]. The squares represent the immunoblobulin-like repeat domains found in the proteins of Leptospira. The C-terminal portion of the LigB protein is represented by the final rectangle. LigA (1224 amino acids and 128 kDa) and LigB (1891 amino acids and 201 kDa) present a region with seven repeated identical domains named LigB (131-645aa) (corresponding to amino acids 131 to 645 of LigA and LigB with 54 kDa, indicated by grey squares).
Figure 2Growth curves of BL21 (DE3) Star™/pAE/LigB (131-645aa). (a) Cell growth at 37°C and 28°C in TB at 200 rpm (errors in absorbance measured at 600 nm of between 1 and 2%). (b) Comparison between uninduced and IPTG-induced growth at 28°C. Induction was performed for 4 h after IPTG was added (equivalent to 7 h process) at Absind = 0.75 (the time when 0.55 mM IPTG was added is indicated by an arrow at 3 h process). As indicated in the scale, 1 h induction was reached after 4 h process, 2 h induction after 5 h process, and 3 h induction after 6 h process, respectively.
Comparison of cell growth during 4 h induction at 28°C (after addition of 0.55 mM IPTG at absorbance 0.75) of BL21 (DE3) Star™/pAE/LigB (131-645aa) after two pre-induction growth temperatures, 28°C and 37°C, at 200 rpm in TB medium with the addition of 0.4% glycerol, 1% de glucose and 100 μg/mL ampicillin
| Cell growth (Abs 600nm) | Soluble LigB (131-645aa) expression (mg/L) | |||
|---|---|---|---|---|
| Post induction time (h) | T growth (pre-induction)28°C | T growth (pre-induction)37°C | T growth (pre-induction)28°C | T growth (pre-induction)37°C |
| Induction | 0.75 | 0.76 | - | - |
| 1 h | 1.36 | 1.40 | 17 | 15 |
| 2 h | 1.69 | 1.80 | 80 | 67 |
| 3 h | 2.25 | 2.29 | 108 | 118 |
| 4 h | 2.73 | 2.97 | 176 | 186 |
Figure 3SDS-PAGE with uninduced and IPTG-induced BL21 (DE3) Star/pAE/LigB (131-645aa) samples normalized by absorbance at 600 nm from assay 3 (Abs = 2.0 and IPTG 0.1 mM), total protein extract separated into soluble and insoluble fractions of recombinant protein in 20 mM Tris/1 mM EDTA/0.1% Triton X-100 (pH8). Unind = uninduced; Ind = induced; TE = Total Extract.
Results for cell growth (measured by absorbance at 600 nm and converted to g (dry cell)/L) of BL21 (DE3) Star™/pAE/LigB (131-645aa), yield (mg/L) and productivity ((mg/L)/h) of soluble recombinant LigB (131-645aa) expressed in shaking flasks at 28°C for 4 h in TB using central composite design for two variables (Abs and IPTG for induction) with triplicate at the central point (CP)
| Induction conditions | Cell growth (4 h ind) | Soluble LigB expression (4 h ind) | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assays | Total process time (h) a | Abs ind(x 1) | IPTG (x 2) | Abs 600nm | Dry cell (g/L) | Model (g/L) b | Yield (mg/L) | Model (mg/L) b | Productivity (mg/L)/h | Model ((mg/L)/h) b | pH | Residual glucose (g/L) |
| 1 | 5.75 | 0.75 (-1) | 0.1 mM (-1) | 3.75 | 0.9 | 0.94 (-4.4%) | 180 | 177 (2%) | 31.3 | 31.2 (0.4%) | 6.64 | 6.4 |
| 2 | 5.83 | 0.75 (-1) | 1.0 mM (+1) | 3.31 | 0.8 | 0.74 (7.5%) | 166 | 163 (2%) | 28.4 | 28.4 (0.1%) | 6.75 | 6.8 |
| 3 | 6.75 | 2.0 (+1) | 0.1 mM (-1) | 6.33 | 1.6 | 1.54 (3.8%) | 288 | 286 (1%) | 42.7 | 42.6 (0.2%) | 6.36 | 5.2 |
| 4 | 7.00 | 2.0 (+1) | 1.0 mM (+1) | 5.19 | 1.3 | 1.34 (-3.1%) | 221 | 218 (1%) | 31.5 | 31.4 (0.5%) | 6.24 | 5.1 |
| CP 1c | 6.25 | 1.4 (0) | 0.55 mM (0) | 4.83 | 1.2 | 1.14 (5.0%) | 198 | 211 (-7%) | 31.7 | 33.4 (-5.4%) | 6.63 | 6.4 |
| CP 2 | 6.25 | 1.4 (0) | 0.55 mM (0) | 4.46 | 1.1 | 1.14 (-3.6%) | 214 | 211 (1%) | 34.2 | 33.4 (2.4%) | 6.53 | 5.8 |
| CP 3 | 6.25 | 1.4 (0) | 0.55 mM (0) | 4.53 | 1.1 | 1.14 (-3.6%) | 210 | 211 (-1%) | 33.6 | 33.4 (0.6%) | 6.55 | 5.1 |
aTotal process time = growth time + 4 h induction. The growth time varied according to the time each culture took to reach the Absind required for the addition of IPTG and induction of LigB (131-645aa).
bModel response obtained for each variable with its relative error in parenthesis (% = ((experimental data - predicted by model)/experimental data) x 100).
cCP is the central point, calculated as the intermediate condition between the inferior (-1) and superior levels (+1) and coded as 0, according to experimental design procedures.
The calculated errors were lower than 12%.
Analysis of variance (ANOVA) for g (dry cell)/L, mg/L and (mg/L)/h responses for soluble LigB (131-645aa) expression
| Response |
|
|
|
|---|---|---|---|
| g (dry cell)/L | 0.98 | 55.3 | 6.94 |
| mg LigB/L | 0.98 | 43.4 | 9.28 |
| (mg LigB/L)/h | 0.97 | 32.3 | 9.28 |
a R 2 = SSModel/SSModel + Residues, b F cal = MSModel/MSResidues, c F tab = F 0.05%, df Model, df Residues.
MS = SS/df where MS = mean squares, SS = sum of squares and df = degrees of freedom.
Figure 4Model representation for the effects of Abs and IPTG on (a) cell growth measured at 600 nm (Abs ) and (b) LigB (131-645aa) productivity ((mg/L)/h) in BL21 (DE3) Star™/pAE.
Figure 5Correlation between soluble LigB (131-645aa) expression (mg/L) in BL21 (DE3) Star™/pAE and cell growth measured at 600 nm (Abs ). The linear correlation is mg/L = 181 (g dry cell)/L or mg/L = 45.3 Abs600nm, that is, (mg L-1)/Abs600nm = 45.3 = YP/X.
Figure 6SDS-PAGE results from protein purification obtained with 300 mM imidazole elution by IMAC. The lysate fraction contains 25-27% LigB (131-645aa) and flow-through contains proteins without binding, leading to enrichment of the protein of interest in the last gel lane.